GSK Loses Bid To Bar Testimony On Avandia Risks

By Erin Marie Daly · January 5, 2011, 1:54 PM EST

GlaxoSmithKline PLC has lost its bid to block three doctors from testifying about the alleged health risks of Avandia in a multidistrict litigation alleging the company concealed the diabetes medication's potential...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Case Number

2:07-md-01871

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Date Filed

October 18, 2007